Evidence map›Paper›PMID 34682420›Full record

SynthesisInternational journal of environmental research and public health2021

Tuberculosis Treatment Outcome and Predictors in Africa: A Systematic Review and Meta-Analysis.

Melese Yeshambaw Teferi, Ziad El-Khatib, Minyahil Tadesse Boltena, Azeb Tarekegn Andualem, Benedict Oppong Asamoah, Mulatu Biru, Hawult Taye Adane

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 5 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 5 syntheses or guidelines pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Regional trends in childhood tuberculosis case notification and treatment outcomes: Tanzania, 2018-2023.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Within-host evolution of drug tolerance inJAC-antimicrobial resistance · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Melese Yeshambaw TeferiArmauer Hansen Research Institute, Ministry of Health, Addis Ababa P.O. Box 1005, Ethiopia.ORCID 0000-0002-7672-9637
Ziad El-KhatibDepartment of Global Public Health, Karolinska Institutet, 171 77 Stockholm, Sweden.ORCID 0000-0003-0756-7280
Minyahil Tadesse BoltenaArmauer Hansen Research Institute, Ministry of Health, Addis Ababa P.O. Box 1005, Ethiopia.ORCID 0000-0002-5081-1480
Azeb Tarekegn AndualemArmauer Hansen Research Institute, Ministry of Health, Addis Ababa P.O. Box 1005, Ethiopia.
Benedict Oppong AsamoahDepartment of Clinical Sciences, Social Medicine and Global Health, Lund University, 221 00 Lund, Sweden.ORCID 0000-0001-7308-1698
Mulatu BiruArmauer Hansen Research Institute, Ministry of Health, Addis Ababa P.O. Box 1005, Ethiopia.ORCID 0000-0002-8370-2571
Hawult Taye AdaneArmauer Hansen Research Institute, Ministry of Health, Addis Ababa P.O. Box 1005, Ethiopia.
Armauer Hansen Research Institute · ETKarolinska Institutet · SELund University · SE

Funding

Ethiopia-Emory TB Research Training ProgramD43TW009127 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Kidist Bobosha · 2013 to 2026
$3.4M
FIC NIH HHS D43 TW009127
6 · The paper itself

Abstract

This review aimed to summarize and estimate the TB treatment success rate and factors associated with unsuccessful TB treatment outcomes in Africa. Potentially eligible primary studies were retrieved from PubMed and Google Scholar. The risk of bias and quality of studies was assessed using The Joanna Briggs Institute's (JBI) appraisal criteria, while heterogeneity across studies was assessed using Cochran's Q test and I2 statistic. Publication bias was checked using the funnel plot and egger's test. The protocol was registered in PROSPERO, numbered CRD42019136986. A total of 26 eligible studies were considered. The overall pooled estimate of TB treatment success rate was found to be 79.0% (95% CI: 76-82%), ranging from 53% (95% CI: 47-58%) in Nigeria to 92% (95% CI: 90-93%) in Ethiopia. The majority of unsuccessful outcomes were attributed to 48% (95% CI: 40-57%) death and 47% (95% CI: 39-55%) of defaulter rate. HIV co-infection and retreatment were significantly associated with an increased risk of unsuccessful treatment outcomes compared to HIV negative and newly diagnosed TB patients with RR of 1.53 (95% CI: 1.36-1.71) and 1.48 (95% CI: 1.14-1.94), respectively. TB treatment success rate was 79% below the WHO defined threshold of 85% with significant variation across countries. Countries need to explore contextual underlining factors and more effort is required in providing TB preventive treatment, improve case screening and linkage for TB treatment among HIV high-risk groups and use confirmatory TB diagnostic modality. Countries in Africa need to strengthen counseling and follow-up, socio-economic support for patients at high risk of loss to follow-up and poor treatment success is also crucial for successful TB control programs.

Indexed as

CoinfectionHIV InfectionsTuberculosisEthiopiaHumansTreatment Outcomemeta-analysisresource-limited settingssystematic reviewtreatment outcomestuberculosis

Identifiers

PMID34682420
PMCPMC8536006
OpenAlexW3206996267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.